{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:00:14Z","timestamp":1794538814047,"version":"4.9.1"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2582294","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T20:37:06Z","timestamp":1764621426000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Cost-effectiveness analysis of anlotinib plus penpulimab versus sorafenib in the treatment of unresectable hepatocellular carcinoma"],"prefix":"10.1080","volume":"21","author":[{"given":"Jiefeng","family":"Luo","sequence":"first","affiliation":[{"name":"Fudan University Shanghai Cancer Center","place":["Shanghai, China"]},{"name":"Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6031-4755","authenticated-orcid":false,"given":"Zhengxiong","family":"Li","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxia","family":"Gui","sequence":"additional","affiliation":[{"name":"Sichuan Electric Power Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Du","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center","place":["Shanghai, China"]},{"name":"Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center","place":["Shanghai, China"]},{"name":"Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.01.006"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30010-2"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14257"},{"key":"e_1_3_6_7_1","unstructured":"American cancer society. Liver cancer survival rates. 2025 [accessed 2025 May 20]. https:\/\/www.cancer.org\/cancer\/types\/liver-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)32453-9"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(21)00110-2"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717002"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.01.007"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(24)00247-4"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00604-5"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.01307"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00343-2"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.04.09"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101350"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.4077"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20240611-00290"},{"key":"e_1_3_6_23_1","unstructured":"The National Comprehensive Cancer Network. Hepatocellular carcinoma. 2025 [accessed 2025 May 22]. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1514."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-5256.2022.02.009"},{"key":"e_1_3_6_25_1","unstructured":"National Health Commission of the People\u2019s Republic of China. Chinese standard for diagnosis and treatment of primary liver cancer. 2024 [accessed 2025 Oct 6]. https:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/48cd549a54204ab1a6247e86adb2dea2.pdf."},{"key":"e_1_3_6_26_1","unstructured":"National institute for Health and Care Excellence. TSD 19: Partitioned survival analysis as a decision modelling tool. 2017 [accessed 2025 May 22]. https:\/\/www.sheffield.ac.uk\/sites\/default\/files\/2022-02\/TSD19-Partitioned-Survival-Analysis-final-report.pdf."},{"key":"e_1_3_6_27_1","volume-title":"China guidelines for pharmacoeconomic evaluations 2020 (Chinese-English Version)","author":"Liu GE","year":"2020","unstructured":"Liu GE, Hu SL, Wu JH, Dong CH, Li HC. China guidelines for pharmacoeconomic evaluations 2020 (Chinese-English Version). Beijing: China Market Press; 2020."},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.2020.244"},{"key":"e_1_3_6_29_1","unstructured":"National Bureau of Statistics of the People\u2019s Republic of China. Statistical bulletin of the People\u2019s Republic of China on national economic and social development 2024. 2025 [accessed 2025 May 22]. https:\/\/www.stats.gov.cn\/sj\/zxfb\/202502\/t20250228_1958817.html."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02273-8"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0037"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.33761"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4846"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1616826"},{"key":"e_1_3_6_36_1","unstructured":"YaoZhi. Chinese drug price of drug centralized bid procurement. 2025 [accessed 2025 May 22]. https:\/\/db.yaozh.com\/yaopinjiage."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0037"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08661-4"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.05.010"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2022.2079498"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12110"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.963058"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1562875"},{"key":"e_1_3_6_44_1","unstructured":"China\u2019s National Healthcare Security Administration. Transcript of the National Healthcare Security Administration\u2019s press conference on the adjustment of the national basic medical insurance work-related injury insurance and maternity insurance drug catalog in 2024. 2024 [accessed 2025 May 27]. https:\/\/www.nhsa.gov.cn\/art\/2024\/11\/28\/art_14_14889.html."},{"key":"e_1_3_6_45_1","unstructured":"Beijing Kangmeng Charity Foundation. Penpulimab patient assistance program. 2021 [accessed 2025 May 27]. https:\/\/www.bjhacf.org\/?p=4361."},{"key":"e_1_3_6_46_1","unstructured":"Beijing Baiqiu\u2019en Public Welfare Foundation. Anrotinib patient assistance program program termination announcement. 2024 [accessed 2025 May 27]. https:\/\/www.bjbqejjh.org.cn\/front\/web\/site.searchshow?mid=81&id=1256."},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.38212\/2224-6614.3542"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(23)00469-2"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00326-6"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5724"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221140662"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.869960"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01752-8"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241310314"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1404389"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01453-0"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.12455"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283x15618129"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2582294","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2582294","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2582294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:33:46Z","timestamp":1786034026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2582294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2582294"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2582294","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2582294"}}